https://stock.noler.com/us/stock/cyclo-therapeutics-inc https://stock.noler.com/us/stock/cyclo-therapeutics-inc/accounts-notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/cyclo-therapeutics-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/cyclo-therapeutics-inc/accounts-receivable-net https://stock.noler.com/us/stock/cyclo-therapeutics-inc/accrued-bonuses-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/cyclo-therapeutics-inc/accumulated-amortization-of-other-deferred-costs https://stock.noler.com/us/stock/cyclo-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/cyclo-therapeutics-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/cyclo-therapeutics-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/cyclo-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/cyclo-therapeutics-inc/adjustments-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/cyclo-therapeutics-inc/advertising-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/cyclo-therapeutics-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/amended-reports-10-k https://stock.noler.com/us/stock/cyclo-therapeutics-inc/amended-reports-10-q https://stock.noler.com/us/stock/cyclo-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/cyclo-therapeutics-inc/area-of-land https://stock.noler.com/us/stock/cyclo-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/cyclo-therapeutics-inc/assets-fair-value-disclosure-recurring https://stock.noler.com/us/stock/cyclo-therapeutics-inc/assets-held-for-sale-property-plant-and-equipment https://stock.noler.com/us/stock/cyclo-therapeutics-inc/assets-noncurrent https://stock.noler.com/us/stock/cyclo-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/cyclo-therapeutics-inc/business-acquisition-cost-of-acquired-entity-transaction-costs https://stock.noler.com/us/stock/cyclo-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/cyclo-therapeutics-inc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/cyclo-therapeutics-inc/cash https://stock.noler.com/us/stock/cyclo-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/cyclo-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/cyclo-therapeutics-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/cyclo-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/cyclo-therapeutics-inc/cash-uninsured-amount https://stock.noler.com/us/stock/cyclo-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/cyclo-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/cyclo-therapeutics-inc/clinical-trials https://stock.noler.com/us/stock/cyclo-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/cyclo-therapeutics-inc/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/cyclo-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/cyclo-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/cyclo-therapeutics-inc/concentration-risk-percentage https://stock.noler.com/us/stock/cyclo-therapeutics-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/cyclo-therapeutics-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/cyclo-therapeutics-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/cost-of-revenue https://stock.noler.com/us/stock/cyclo-therapeutics-inc/costs-and-expenses https://stock.noler.com/us/stock/cyclo-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/cyclo-therapeutics-inc/current-assets https://stock.noler.com/us/stock/cyclo-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/cyclo-therapeutics-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-face-amount https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-issued https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-periodic-payment https://stock.noler.com/us/stock/cyclo-therapeutics-inc/debt-repaid https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-costs https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-costs-current-and-noncurrent https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-federal-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-impairment-losses https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-legal-settlements https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/cyclo-therapeutics-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/cyclo-therapeutics-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/cyclo-therapeutics-inc/deposit-liability-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/depreciation https://stock.noler.com/us/stock/cyclo-therapeutics-inc/depreciation-and-amortization https://stock.noler.com/us/stock/cyclo-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/depreciation-nonproduction https://stock.noler.com/us/stock/cyclo-therapeutics-inc/disposal-group-including-discontinued-operation-property-plant-and-equipment https://stock.noler.com/us/stock/cyclo-therapeutics-inc/disposal-group-including-discontinued-operation-property-plant-and-equipment-noncurrent https://stock.noler.com/us/stock/cyclo-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/cyclo-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/cyclo-therapeutics-inc/entity-wide-revenue-major-customer-percentage https://stock.noler.com/us/stock/cyclo-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/cyclo-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/cyclo-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/cyclo-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/cyclo-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/cyclo-therapeutics-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/cyclo-therapeutics-inc/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/gain-loss-on-disposition-of-property https://stock.noler.com/us/stock/cyclo-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/cyclo-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/cyclo-therapeutics-inc/gross-profit https://stock.noler.com/us/stock/cyclo-therapeutics-inc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/cyclo-therapeutics-inc/income-tax https://stock.noler.com/us/stock/cyclo-therapeutics-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/cyclo-therapeutics-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/cyclo-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/cyclo-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/cyclo-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/cyclo-therapeutics-inc/increase-decrease-in-deferred-income-taxes https://stock.noler.com/us/stock/cyclo-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/cyclo-therapeutics-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/cyclo-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/cyclo-therapeutics-inc/increase-decrease-in-other-noncurrent-assets-and-liabilities-net https://stock.noler.com/us/stock/cyclo-therapeutics-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/cyclo-therapeutics-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/increase-decrease-in-prepaid-insurance https://stock.noler.com/us/stock/cyclo-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/cyclo-therapeutics-inc/insider-transactions-preferred/purchases https://stock.noler.com/us/stock/cyclo-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/cyclo-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/cyclo-therapeutics-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/cyclo-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/cyclo-therapeutics-inc/interest-costs-capitalized https://stock.noler.com/us/stock/cyclo-therapeutics-inc/interest-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/cyclo-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/cyclo-therapeutics-inc/inventory https://stock.noler.com/us/stock/cyclo-therapeutics-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/cyclo-therapeutics-inc/inventory-work-in-process https://stock.noler.com/us/stock/cyclo-therapeutics-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/cyclo-therapeutics-inc/inventory-write-down https://stock.noler.com/us/stock/cyclo-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/cyclo-therapeutics-inc/investment-income-nonoperating https://stock.noler.com/us/stock/cyclo-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/cyclo-therapeutics-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/cyclo-therapeutics-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/cyclo-therapeutics-inc/lease-income https://stock.noler.com/us/stock/cyclo-therapeutics-inc/legal-fees https://stock.noler.com/us/stock/cyclo-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/cyclo-therapeutics-inc/lessor-operating-lease-payments-to-be-received-next-twelve-months https://stock.noler.com/us/stock/cyclo-therapeutics-inc/liabilities-assumed https://stock.noler.com/us/stock/cyclo-therapeutics-inc/liabilities-fair-value-disclosure-recurring https://stock.noler.com/us/stock/cyclo-therapeutics-inc/liabilities-noncurrent https://stock.noler.com/us/stock/cyclo-therapeutics-inc/line-of-credit https://stock.noler.com/us/stock/cyclo-therapeutics-inc/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/cyclo-therapeutics-inc/line-of-credit-facility-current-borrowing-capacity https://stock.noler.com/us/stock/cyclo-therapeutics-inc/line-of-credit-facility-interest-rate-at-period-end https://stock.noler.com/us/stock/cyclo-therapeutics-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/cyclo-therapeutics-inc/lines-of-credit-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/long-lived-assets-held-for-sale-impairment-charge https://stock.noler.com/us/stock/cyclo-therapeutics-inc/long-term-accounts-notes-and-loans-receivable-net-noncurrent https://stock.noler.com/us/stock/cyclo-therapeutics-inc/long-term-debt https://stock.noler.com/us/stock/cyclo-therapeutics-inc/long-term-debt-percentage-bearing-fixed-interest-rate https://stock.noler.com/us/stock/cyclo-therapeutics-inc/long-term-notes-payable https://stock.noler.com/us/stock/cyclo-therapeutics-inc/maintenance-costs https://stock.noler.com/us/stock/cyclo-therapeutics-inc/mortgage-loan-related-to-property-sales https://stock.noler.com/us/stock/cyclo-therapeutics-inc/mortgage-loans-on-real-estate-carrying-amount-of-mortgages https://stock.noler.com/us/stock/cyclo-therapeutics-inc/mortgage-loans-on-real-estate-face-amount-of-mortgages https://stock.noler.com/us/stock/cyclo-therapeutics-inc/mortgage-loans-on-real-estate-face-amount-of-mortgages-2 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/mortgage-loans-on-real-estate-interest-rate https://stock.noler.com/us/stock/cyclo-therapeutics-inc/mortgage-loans-on-real-estate-interest-rate-2 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/cyclo-therapeutics-inc/net-income https://stock.noler.com/us/stock/cyclo-therapeutics-inc/noncash-or-part-noncash-acquisition-debt-assumed https://stock.noler.com/us/stock/cyclo-therapeutics-inc/noninterest-expense-directors-fees https://stock.noler.com/us/stock/cyclo-therapeutics-inc/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/notes-payable https://stock.noler.com/us/stock/cyclo-therapeutics-inc/notes-payable-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/cyclo-therapeutics-inc/officers-compensation https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-income https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-lease-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/cyclo-therapeutics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/cyclo-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/other-cost-and-expense-operating https://stock.noler.com/us/stock/cyclo-therapeutics-inc/other-current-assets https://stock.noler.com/us/stock/cyclo-therapeutics-inc/other-income https://stock.noler.com/us/stock/cyclo-therapeutics-inc/other-noncash-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/cyclo-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/other-sales-revenue-net https://stock.noler.com/us/stock/cyclo-therapeutics-inc/other-selling-general-and-administrative-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/cyclo-therapeutics-inc/patents-active https://stock.noler.com/us/stock/cyclo-therapeutics-inc/patents-pending https://stock.noler.com/us/stock/cyclo-therapeutics-inc/patents-rejected https://stock.noler.com/us/stock/cyclo-therapeutics-inc/payments-for-advance-to-affiliate https://stock.noler.com/us/stock/cyclo-therapeutics-inc/payments-for-proceeds-from-loans-receivable https://stock.noler.com/us/stock/cyclo-therapeutics-inc/payments-of-loan-costs https://stock.noler.com/us/stock/cyclo-therapeutics-inc/payments-of-merger-related-costs-financing-activities https://stock.noler.com/us/stock/cyclo-therapeutics-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/cyclo-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/cyclo-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/cyclo-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/cyclo-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/cyclo-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/cyclo-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/cyclo-therapeutics-inc/prepaid-expense-noncurrent https://stock.noler.com/us/stock/cyclo-therapeutics-inc/prepaid-insurance https://stock.noler.com/us/stock/cyclo-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-other-operating-activities https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-sale-of-property-held-for-sale https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/cyclo-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/cyclo-therapeutics-inc/professional-fees https://stock.noler.com/us/stock/cyclo-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/cyclo-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/cyclo-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/cyclo-therapeutics-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/cyclo-therapeutics-inc/public-float https://stock.noler.com/us/stock/cyclo-therapeutics-inc/purchase-commitment-remaining-minimum-amount-committed https://stock.noler.com/us/stock/cyclo-therapeutics-inc/real-estate-heldforsale https://stock.noler.com/us/stock/cyclo-therapeutics-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/cyclo-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/cyclo-therapeutics-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/cyclo-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/cyclo-therapeutics-inc/restricted-stock-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/cyclo-therapeutics-inc/revenue https://stock.noler.com/us/stock/cyclo-therapeutics-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/cyclo-therapeutics-inc/salaries-and-wages https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sales-revenue-services-net https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-10-k https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-10-q https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-10ksb https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-10qsb https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-15-12g https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-25-nse https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-425 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-8-k https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-ars https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-cert https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-def-14a https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-def-14c https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-prer14c https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-s-4 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sec-filings-sb-2 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/cyclo-therapeutics-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/cyclo-therapeutics-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/cyclo-therapeutics-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/secondary-offerings-form-s-1mef https://stock.noler.com/us/stock/cyclo-therapeutics-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/cyclo-therapeutics-inc/selling-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-lower-range-limit https://stock.noler.com/us/stock/cyclo-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/cyclo-therapeutics-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-upper-range-limit https://stock.noler.com/us/stock/cyclo-therapeutics-inc/share-price https://stock.noler.com/us/stock/cyclo-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/cyclo-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/cyclo-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/cyclo-therapeutics-inc/shares-issued-for-stock-awards https://stock.noler.com/us/stock/cyclo-therapeutics-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/cyclo-therapeutics-inc/shares-outstanding-2 https://stock.noler.com/us/stock/cyclo-therapeutics-inc/shares-subject-to-mandatory-redemption-settlement-terms-amount-current https://stock.noler.com/us/stock/cyclo-therapeutics-inc/shipping-handling-and-transportation-costs https://stock.noler.com/us/stock/cyclo-therapeutics-inc/short-term-debt https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-compensation-cost https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-payments https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-non-option-equity-instruments-exercised https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-non-option-equity-instruments-granted https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-non-option-equity-instruments-outstanding-number https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-purchase-price-of-common-stock-percent https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-award-shares-purchased-for-award https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-compensation-allocation-of-recognized-period-costs-capitalized-amount https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-granted-value-share-based-compensation-gross https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-shares-issued-for-acquisitions https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-shares-issued-shares-purchase-of-assets https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-shares-issued-shares-share-based-compensation-gross https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-option-plan-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/cyclo-therapeutics-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/cyclo-therapeutics-inc/sublease-income https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/cyclo-therapeutics-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/cyclo-therapeutics-inc/total-assets https://stock.noler.com/us/stock/cyclo-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/cyclo-therapeutics-inc/total-long-term-debt https://stock.noler.com/us/stock/cyclo-therapeutics-inc/trade-and-loans-receivables-held-for-sale-net-not-part-of-disposal-group https://stock.noler.com/us/stock/cyclo-therapeutics-inc/treasury-stock-reissued-at-lower-than-repurchase-price https://stock.noler.com/us/stock/cyclo-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/cyclo-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/cyclo-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/cyclo-therapeutics-inc/valuation-allowance-for-impairment-of-recognized-servicing-assets-sales https://stock.noler.com/us/stock/cyclo-therapeutics-inc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/cyclo-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/cyclo-therapeutics-inc/weighted-average-number-of-shares-issued-basic https://stock.noler.com/us/stock/cyclo-therapeutics-inc/write-off-of-deferred-debt-issuance-cost